Brief: Prime Medicine Presents Prime Editing Data in Non-human Primates
27/10/2023 11:02
Oct 27 (Reuters) - Prime Medicine Inc PRME.O :
* PRIME MEDICINE PRESENTS FIRST-EVER PRIME EDITING DATA IN
NON-HUMAN PRIMATES DEMONSTRATING HIGHLY EFFICIENT ABILITY OF
PRIME EDITORS TO PRECISELY CORRECT DISEASE-CAUSING MUTATION OF
GSD1B
* PRIME MEDICINE INC - NO DETECTABLE OFF-TARGET EDITS
OBSERVED
FOLLOWING COMPREHENSIVE IN VITRO ANALYSIS
* PRIME MEDICINE INC - UP TO 56% WHOLE LIVER EDITING
OBSERVED IN
HUMANIZED GSD1B MOUSE MODEL
Source text for Eikon: ID:nGNX725XHY
Further company coverage: PRME.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prime Medicine
See all newsBrief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm647 In Alpha-1 Antitrypsin Deficiency
Prime Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Prime Medicine Q2 net loss narrows on lower expenses
Brief: Prime Medicine, Inc. Q2 EPS USD -0.24
Brief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm577a In H1069q-Mutated Wilson Disease